Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 23.12.2019 | EN | Official Journal of the European Union | C 432/42 |

---

Judgment of the General Court of 7 November 2019 — Intas Pharmaceuticals v EUIPO — Laboratorios Indas (INTAS)

(Case T-380/18) [(1)](#ntr1-C_2019432EN.01004201-E0001)

(EU trade mark - Opposition proceedings - Application for the EU word mark INTAS - Earlier EU and national figurative trade marks including the word element ‘indas’ - Relative ground for refusal - Likelihood of confusion - Similarity of the signs and of the goods - Article 8(1)(b) of Regulation (EU) 2017/1001 - Proof of genuine use of the earlier marks - Article 47 of Regulation 2017/1001)

(2019/C 432/48)

Language of the case: English

Parties

Applicant: Intas Pharmaceuticals Ltd (Ahmedabad, India) (represented by: F. Traub, lawyer)

Defendant: European Union Intellectual Property Office (represented by: J. Crespo Carrillo and H. O’Neill, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Laboratorios Indas, SA (Pozuelo de Alarcón, Spain) (represented by: A. Gómez López, lawyer)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 16 April 2018 (Case R 815/2017-4), relating to opposition proceedings between Laboratorios Indas and Intas Pharmaceuticals.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Intas Pharmaceuticals Ltd to pay the costs. |

---

---

[Top](#document1)